Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Apr 16, 2026
Sale
Shares
2,048
Price
$577.03
Total Value
$1.18M
Shares Held After
44,835
% of Holdings
4.4%
Apr 16, 2026
Sale
Shares
930
Price
$575.99
Total Value
$535.67K
Shares Held After
46,883
% of Holdings
1.9%
Apr 16, 2026
Sale
Shares
1,800
Price
$574.79
Total Value
$1.03M
Shares Held After
47,813
% of Holdings
3.6%
Apr 16, 2026
Sale
Shares
400
Price
$573.96
Total Value
$229.58K
Shares Held After
49,613
% of Holdings
0.8%

Whitehawk Therapeutics, Inc. (WHWK)

Giacobello Scott M. — CHIEF FINANCIAL OFFICER
Apr 16, 2026
Sale
Shares
141,600
Price
$4.13
Total Value
$584.81K
Shares Held After
295,224
% of Holdings
32.4%

Phreesia, Inc. (PHR)

Hui Yvonne — Principal Accounting Officer
Apr 16, 2026
Sale
Shares
10,063
Price
$9.08
Total Value
$91.37K
Shares Held After
25,991
% of Holdings
27.9%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 16, 2026
Sale
Shares
40
Price
$581.64
Total Value
$23.27K
Shares Held After
18,876
% of Holdings
0.2%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 16, 2026
Sale
Shares
160
Price
$581.08
Total Value
$92.97K
Shares Held After
18,916
% of Holdings
0.8%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 16, 2026
Sale
Shares
1,454
Price
$579.64
Total Value
$842.79K
Shares Held After
19,076
% of Holdings
7.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 16, 2026
Sale
Shares
1,066
Price
$578.83
Total Value
$617.03K
Shares Held After
20,530
% of Holdings
4.9%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 16, 2026
Sale
Shares
2,085
Price
$577.87
Total Value
$1.20M
Shares Held After
21,596
% of Holdings
8.8%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 16, 2026
Sale
Shares
2,206
Price
$576.91
Total Value
$1.27M
Shares Held After
23,681
% of Holdings
8.5%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 16, 2026
Sale
Shares
789
Price
$575.64
Total Value
$454.18K
Shares Held After
25,887
% of Holdings
3.0%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 16, 2026
Sale
Shares
1,680
Price
$574.73
Total Value
$965.55K
Shares Held After
26,676
% of Holdings
5.9%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Apr 16, 2026
Sale
Shares
520
Price
$573.91
Total Value
$298.44K
Shares Held After
28,356
% of Holdings
1.8%

Butterfly Network, Inc. (BFLY)

Cashman Steve — Chief Business Officer
Apr 16, 2026
Sale
Shares
200,000
Price
$5.22
Total Value
$1.04M
Shares Held After
2,177,386
% of Holdings
8.4%

Liquidia Corp (LQDA)

JEFFS ROGER — Director
Apr 16, 2026
Sale
Shares
25,000
Price
$40.31
Total Value
$1.01M
Shares Held After
1,441,934
% of Holdings
1.7%

HeartBeam, Inc. (BEAT)

Elfrink Willem — Director
Apr 16, 2026
Purchase
Shares
187,500
Price
$0.80
Total Value
$150.00K
Shares Held After
538,667
% of Holdings
34.8%
Apr 16, 2026
Purchase
Shares
25,000
Price
$0.80
Total Value
$20.00K
Shares Held After
137,293
% of Holdings
18.2%

HeartBeam, Inc. (BEAT)

ENO Robert Paul — President
Apr 16, 2026
Purchase
Shares
12,500
Price
$0.80
Total Value
$10.00K
Shares Held After
36,742
% of Holdings
34.0%

HeartBeam, Inc. (BEAT)

STROME MARK E — Director
Apr 16, 2026
Purchase
Shares
750,000
Price
$0.80
Total Value
$600.00K
Shares Held After
3,650,000
% of Holdings
20.5%

HeartBeam, Inc. (BEAT)

JAFF MICHAEL R — Director
Apr 16, 2026
Purchase
Shares
31,250
Price
$0.80
Total Value
$25.00K
Shares Held After
31,250
% of Holdings
100.0%
Apr 16, 2026
Purchase
Shares
31,250
Price
$0.80
Total Value
$25.00K
Shares Held After
909,914
% of Holdings
3.4%

HeartBeam, Inc. (BEAT)

Ferrari Richard — Director
Apr 16, 2026
Purchase
Shares
62,500
Price
$0.80
Total Value
$50.00K
Shares Held After
291,636
% of Holdings
21.4%
Apr 16, 2026
Purchase
Shares
31,250
Price
$0.80
Total Value
$25.00K
Shares Held After
72,230
% of Holdings
43.3%
Apr 16, 2026
Sale
Shares
1,850
Price
$54.88
Total Value
$101.52K
Shares Held After
117,000
% of Holdings
1.6%
Apr 16, 2026
Sale
Shares
5,190
Price
$54.56
Total Value
$283.14K
Shares Held After
118,850
% of Holdings
4.2%
Apr 16, 2026
Sale
Shares
19,060
Price
$14.18
Total Value
$270.27K
Shares Held After
408,160
% of Holdings
4.5%
Apr 16, 2026
Sale
Shares
116
Price
$84.83
Total Value
$9.84K
Shares Held After
8,528
% of Holdings
1.3%
Apr 16, 2026
Sale
Shares
226,906
Price
$45.34
Total Value
$10.29M
Shares Held After
3,020,119
% of Holdings
7.0%
Apr 16, 2026
Sale
Shares
226,906
Price
$45.34
Total Value
$10.29M
Shares Held After
3,020,119
% of Holdings
7.0%

Aura Biosciences, Inc. (AURA)

Kilroy Conor — Chief Legal Officer and Secretary.
Apr 16, 2026
Sale
Shares
11,738
Price
$7.02
Total Value
$82.40K
Shares Held After
217,835
% of Holdings
5.1%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Apr 16, 2026
Sale
Shares
1,294
Price
$578.21
Total Value
$748.20K
Shares Held After
45,172
% of Holdings
2.8%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Apr 16, 2026
Sale
Shares
3,366
Price
$577.39
Total Value
$1.94M
Shares Held After
46,466
% of Holdings
6.8%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Apr 16, 2026
Sale
Shares
1,800
Price
$576.38
Total Value
$1.04M
Shares Held After
49,832
% of Holdings
3.5%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Apr 16, 2026
Sale
Shares
1,640
Price
$575.37
Total Value
$943.61K
Shares Held After
51,632
% of Holdings
3.1%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Apr 16, 2026
Sale
Shares
200
Price
$574.03
Total Value
$114.81K
Shares Held After
53,272
% of Holdings
0.4%

ENCISION INC (ECIA)

FRIES ROBERT H — Director
Apr 15, 2026
Purchase
Shares
155,535
Price
$0.14
Total Value
$21.77K
Shares Held After
1,495,535
% of Holdings
10.4%

Valion Bio, Inc. (VBIO)

Bolton Sheryle — Director
Apr 15, 2026
Purchase
Shares
10,000
Price
$1.04
Total Value
$10.40K
Shares Held After
10,000
% of Holdings
100.0%

Clene Inc. (CLNN)

Ugwumba Chidozie — 10% Owner
Apr 15, 2026
Sale
Shares
6,374
Price
$6.48
Total Value
$41.30K
Shares Held After
395,517
% of Holdings
1.6%
Apr 15, 2026
Sale
Shares
534
Price
$76.97
Total Value
$41.10K
Shares Held After
51,344
% of Holdings
1.0%
Apr 15, 2026
Sale
Shares
4,466
Price
$76.19
Total Value
$340.26K
Shares Held After
51,878
% of Holdings
7.9%
Apr 15, 2026
Sale
Shares
120,000
Price
$150.09
Total Value
$18.01M
Shares Held After
276,698
% of Holdings
30.2%

Septerna, Inc. (SEPN)

Bhatt Elizabeth — President and COO
Apr 15, 2026
Sale
Shares
326
Price
$25.86
Total Value
$8.43K
Shares Held After
174,209
% of Holdings
0.2%

Septerna, Inc. (SEPN)

Bhatt Elizabeth — President and COO
Apr 15, 2026
Sale
Shares
1,101
Price
$25.24
Total Value
$27.79K
Shares Held After
174,535
% of Holdings
0.6%

Septerna, Inc. (SEPN)

Bhatt Elizabeth — President and COO
Apr 15, 2026
Sale
Shares
2,573
Price
$23.76
Total Value
$61.12K
Shares Held After
175,636
% of Holdings
1.4%

MapLight Therapeutics, Inc. (MPLT)

Lillie James Woodruff — Chief Scientific Officer
Apr 15, 2026
Sale
Shares
1,730
Price
$26.82
Total Value
$46.40K
Shares Held After
297,940
% of Holdings
0.6%

MapLight Therapeutics, Inc. (MPLT)

Kreitzer Anatol — Chief Discovery Officer
Apr 15, 2026
Sale
Shares
3,316
Price
$26.61
Total Value
$88.24K
Shares Held After
256,612
% of Holdings
1.3%
Apr 15, 2026
Sale
Shares
3,590
Price
$26.61
Total Value
$95.53K
Shares Held After
251,054
% of Holdings
1.4%

MapLight Therapeutics, Inc. (MPLT)

Setia Vishwas — Chief Financial Officer
Apr 15, 2026
Sale
Shares
2,806
Price
$26.87
Total Value
$75.40K
Shares Held After
392,743
% of Holdings
0.7%
Version: v26.5.2